HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Usefulness of plasma copeptin as a biomarker to predict the therapeutic effectiveness of metoprolol for postural tachycardia syndrome in children.

Abstract
Metoprolol is clinically used to treat postural tachycardia syndrome (POTS) in children, but its effectiveness is unsatisfactory. Biomarkers to predict therapeutic efficacy are needed. We aimed to explore changes in the plasma copeptin level for assessing the therapeutic efficacy of metoprolol for POTS in children. We included 49 children with POTS and 25 healthy children as controls. Patients received metoprolol for 1.5 to 3 months. The plasma copeptin level was measured by sandwich immunoluminometric assay. The area under the receiver operating characteristic curve was used to explore the predictive value of the plasma copeptin level. The baseline plasma copeptin level was higher in children with POTS than controls (10.524 ± 2.016 vs 8.750 ± 1.419 pmol/L, p <0.001) and was lower for responders than nonresponders to metoprolol (9.377 ± 1.411 vs 12.054 ± 1.662 pmol/L, p = 0.003). The area under the receiver operating characteristic curve was 0.889 (95% confidence interval 0.799 to 0.980). With a baseline plasma copeptin level of 10.225 pmol/L as a cutoff, the sensitivity was 90.5% and specificity 78.6% in predicting the efficacy of metoprolol in children with POTS. In conclusion, the baseline plasma copeptin level can be used as a biomarker to predict the therapeutic effectiveness of metoprolol in children with POTS.
AuthorsJuan Zhao, Shuxu Du, Jinyan Yang, Jing Lin, Chaoshu Tang, Junbao Du, Hongfang Jin
JournalThe American journal of cardiology (Am J Cardiol) Vol. 114 Issue 4 Pg. 601-5 (Aug 15 2014) ISSN: 1879-1913 [Electronic] United States
PMID24996552 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • Anti-Arrhythmia Agents
  • Biomarkers
  • Glycopeptides
  • Protein Precursors
  • copeptins
  • Metoprolol
Topics
  • Adolescent
  • Anti-Arrhythmia Agents (administration & dosage)
  • Biomarkers (blood)
  • Child
  • Dose-Response Relationship, Drug
  • Electrocardiography
  • Female
  • Follow-Up Studies
  • Glycopeptides (blood)
  • Heart Rate (drug effects, physiology)
  • Humans
  • Male
  • Metoprolol (administration & dosage)
  • Postural Orthostatic Tachycardia Syndrome (blood, drug therapy, physiopathology)
  • Posture (physiology)
  • Predictive Value of Tests
  • Protein Precursors
  • ROC Curve
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: